Lario Therapeutics awarded $6M Grant from The Michael J. Fox Foundation for Parkinson’s Research

FHS
July 23, 2024
12:54 pm

Award supports preclinical research of Lario’s CaV2.3 calcium channel inhibitors as a novel disease-modifying approach for treatment of Parkinson’s disease.

BayCare to Deploy Cadence’s Remote Patient Monitoring Platform

What You Should Know: – BayCare, a healthcare system, has announced a strategic partnership with Cadence, a chronic disease management company, to implement a comprehensive

August 20, 2024

FDA spells out new expedited withdrawal procedures for accelerated approvals

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 6, 2024

World-first type 1 diabetes risk screening study in adults opens for recruitment

A world-first research programme led by the University of Bristol that will identify adults at high risk of developing type 1 diabetes opens for recruitment.

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.